• Profile
Close

Pre-diagnostic serum levels of fatty acid metabolites and risk of ovarian cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial

Cancer Epidemiology, Biomarkers & Prevention Oct 04, 2018

Hada M, et al. - In a nested case-control study (157 cases/156 matched controls) within the PLCO Cancer Screening Trial, researchers assessed the link between pre-diagnostic serum levels of 31 arachidonic acid/linoleic acid/alpha-linoleic acid metabolites and ovarian cancer risk using unconditional logistic regression, since inflammation has been suggested to increase ovarian cancer risk and aspirin has been shown to decrease ovarian cancer risk. They found that, there was an increased risk of developing ovarian cancer in the following decade among women with increased levels of five fatty acid metabolites (8-HETE, 12,13-DHOME, 13-HODE, 9-HODE, and 9,12,13-THOME). They also noted that, via metabolism through the LOX/cytochrome P450 pathway, all five metabolites were derived from either arachidonic acid (8-HETE) or linoleic acid (12,13-DHOME, 13-HODE, 9-HODE, 9,12,13-THOME).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay